Matrix metallopropteinases in heart failure.
Heart failure (HF) represents a complex multifactorial syndrome, characterized by crucial structural and functional abnormalities of the myocardium. Matrix metalloproteinases are associated with left ventricular dysfunction, adverse left ventricular remodelling and prognosis after acute myocardial i...
Những tác giả chính: | Tousoulis, D, Kampoli, A, Papageorgiou, N, Antoniades, C, Siasos, G, Latsios, G, Tsiamis, E, Stefanadis, C |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2012
|
Những quyển sách tương tự
-
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
Bằng: Kampoli, A, et al.
Được phát hành: (2012) -
Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
Bằng: Briasoulis, A, et al.
Được phát hành: (2012) -
Circulating biomarkers for the diagnosis and prognosis of heart failure.
Bằng: Tousoulis, D, et al.
Được phát hành: (2009) -
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
Bằng: Gounari, P, et al.
Được phát hành: (2010) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
Bằng: Tousoulis, D, et al.
Được phát hành: (2011)